Skip to content

Home - Media - Press releases    
31 January 2008
Fourth Quarter and Full Year Results 2007

“Earnings per share for the full year ahead of target. With the addition of six new molecules to the late stage pipeline during 2007, there are now 10 projects in Phase III development.”

AstraZeneca PLC - Fourth Quarter and Full Year Results 2007

 Download the narrative and the figures.

Media Enquiries:
Steve Brown/Edel McCaffrey (London) - (020) 7304 5033/5034
Staffan Ternby (Södertälje) - (8) 553 26107
Earl Whipple (Wilmington) - (302) 885 8197

Analyst/Investor Enquiries:
Karl Hard/Jonathan Hunt (London) - (020) 7304 5322/5087
Staffan Ternby (Södertälje) - (8) 553 26107
Ed Seage/Jörgen Winroth (USA) - (302) 886 4065/(212) 579 0506
Peter Vozzo (MedImmune) - (301) 398 4358
AstraZeneca websites
Search
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008